Explore more publications!

Africa News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Observer.

Press releases published on November 5, 2025

Normunity announces first patient dosed in Phase 1 clinical study of NRM-823, a T Cell Engager against a novel tumor-specific target, in patients with solid tumors
Kailera Therapeutics to Participate in Upcoming November Investor Conferences
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2025 Financial Results
Ardelyx to Participate at the Jefferies Global Healthcare Conference in London
Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights
Altimmune to Participate in Two Upcoming Investor Conferences
TERRA CLEAN CLOSES $2.5 MILLION LIFE OFFERING
Crescent Biopharma to Present at November Investor Conferences
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Secura Bio to Participate in the Jefferies Global Healthcare Conference in London
Apellis Pharmaceuticals to Present at the Stifel 2025 Healthcare Conference
Foghorn Therapeutics Provides Third Quarter 2025 Financial and Corporate Update
BioCryst to Present at Upcoming Investor Conference
Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights
Arvinas Reports Third Quarter 2025 Financial Results and Provides Corporate Update
NevGold Announces Up to 85% Antimony Recovery From Positive Phase II Metallurgical Testwork at Oxide Gold-Antimony Limo Butte Project in Nevada
atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies
Clearmind Expands Global IP Protection for MEAI in Depression Treatment with New South Korea Patent Filing
Fortrea Reports Third Quarter 2025 Results
Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions